IC

Ikarian Capital Portfolio holdings

AUM $302M
1-Year Return 65.21%
This Quarter Return
+22.57%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$329M
AUM Growth
+$61.1M
Cap. Flow
-$36.5M
Cap. Flow %
-11.09%
Top 10 Hldgs %
43.78%
Holding
155
New
31
Increased
13
Reduced
30
Closed
17

Top Buys

1
CLDX icon
Celldex Therapeutics
CLDX
$21.4M
2
BPMC
Blueprint Medicines
BPMC
$15.7M
3
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$9.46M
4
GOSS icon
Gossamer Bio
GOSS
$9.15M
5
BDTX icon
Black Diamond Therapeutics
BDTX
$7.49M

Top Sells

1
BTAI icon
BioXcel Therapeutics
BTAI
$22.5M
2
XLRN
Acceleron Pharma Inc.
XLRN
$21.5M
3
ARGX icon
argenx
ARGX
$14.4M
4
IMVT icon
Immunovant
IMVT
$13.6M
5
MYOV
Myovant Sciences Ltd.
MYOV
$8.74M

Sector Composition

1 Healthcare 96.18%
2 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TVRD
26
Tvardi Therapeutics, Inc. Common Stock
TVRD
$284M
$4.68M 0.37%
7,598
-7,740
-50% -$4.76M
PCVX icon
27
Vaxcyte
PCVX
$4.19B
$4.42M 0.35%
+139,813
New +$4.42M
CHAQ.U
28
DELISTED
Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one
CHAQ.U
$4.2M 0.33%
+400,000
New +$4.2M
BMY.RT
29
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$3.94M 0.31%
1,100,000
+150,000
+16% +$537K
AVDL
30
Avadel Pharmaceuticals
AVDL
$1.48B
$3.94M 0.31%
487,143
+405,000
+493% +$3.27M
OTIC
31
DELISTED
Otonomy, Inc.
OTIC
$3.86M 0.31%
1,067,271
-300,000
-22% -$1.09M
XENE icon
32
Xenon Pharmaceuticals
XENE
$2.97B
$3.74M 0.3%
298,173
-145,409
-33% -$1.82M
ASMB icon
33
Assembly Biosciences
ASMB
$176M
$3.67M 0.29%
13,122
– –
VSTM icon
34
Verastem
VSTM
$671M
$3.29M 0.26%
159,444
-278,258
-64% -$5.74M
ACET icon
35
Adicet Bio
ACET
$59.2M
$3.12M 0.25%
+207,507
New +$3.12M
ICAD
36
DELISTED
iCAD Inc
ICAD
$3.12M 0.25%
312,268
+205,165
+192% +$2.05M
RIGL icon
37
Rigel Pharmaceuticals
RIGL
$712M
$3.08M 0.24%
168,053
– –
ALLK
38
DELISTED
Allakos
ALLK
$3.06M 0.24%
+42,536
New +$3.06M
AGTC
39
DELISTED
Applied Genetic Technologies Corporation
AGTC
$3.02M 0.24%
545,884
– –
CASI icon
40
CASI Pharmaceuticals
CASI
$34.9M
$2.6M 0.21%
103,991
– –
APTX
41
DELISTED
Aptinyx Inc. Common Stock
APTX
$2.46M 0.2%
591,000
– –
SLDB icon
42
Solid Biosciences
SLDB
$426M
$2.31M 0.18%
52,534
+16,597
+46% +$729K
ACAD icon
43
Acadia Pharmaceuticals
ACAD
$4.25B
$2.23M 0.18%
+46,008
New +$2.23M
ZYNE
44
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$2.18M 0.17%
+647,400
New +$2.18M
ALT icon
45
Altimmune
ALT
$316M
$1.77M 0.14%
+165,000
New +$1.77M
ACHV icon
46
Achieve Life Sciences
ACHV
$138M
$1.45M 0.12%
+182,927
New +$1.45M
CLLS
47
Cellectis
CLLS
$261M
$1.3M 0.1%
73,067
+42,139
+136% +$750K
MBIO icon
48
Mustang Bio
MBIO
$10.6M
$1.13M 0.09%
475
– –
ADMA icon
49
ADMA Biologics
ADMA
$4.02B
$1.11M 0.09%
378,574
-251,426
-40% -$737K
AVTX icon
50
Avalo Therapeutics
AVTX
$142M
$1.05M 0.08%
140
-56
-29% -$419K
1
2
3 4 5